During the past decade, Mary M. Gooley Hemophilia Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary M. Gooley Hemophilia Center" #1 collaborator was "Shire" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Bioverativ Therapeutics Inc." with 1 trials as a collaborator and "CSL Behring" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Mary M. Gooley Hemophilia Center" are "Hemophilia" (2 trials), "Blood Coagulation Disorders" (1 trials), "Blood Platelet Disorders" (1 trials), "Hematologic Disease" (1 trials) and "Menorrhagia" (1 trials). Many other conditions were trialed in "Mary M. Gooley Hemophilia Center" in a lesser frequency.

Most popular intervention types in "Mary M. Gooley Hemophilia Center" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Complete Bleeding Symptom ISTH Bleeding Assessment Tool" (1 trials), "Cyclokapron" (1 trials), "Desmopressin Acetate" (1 trials), "Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013" (1 trials) and "Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mary M. Gooley Hemophilia Center" are 3 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Mary M. Gooley Hemophilia Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mary M. Gooley Hemophilia Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mary M. Gooley Hemophilia Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".